Skip to main content
Top
Published in: Reproductive Medicine and Biology 1/2014

01-01-2014 | Original Article

Simple, sensitive and reliable in vivo assays to evaluate the estrogenic activity of endocrine disruptors

Authors: Kanya Anukulthanakorn, Sukanya Jareonporn, Suchinda Malaivijitnond

Published in: Reproductive Medicine and Biology | Issue 1/2014

Login to get access

Abstract

Purpose

We compared three in vivo assays, determining changes of body weight, and uterotropic and vaginal cytology assays, for the evaluation of estrogenic activity of an estrogen disrupting compound, Pueraria mirifica (PM), in comparison with 17β-estradiol (E).

Methods

Female rats were ovariectomized and gavaged with distilled water, 0.01, 0.1, 1, 10 and 20 mg/kg BW/day of E and 100 and 1,000 mg/kg BW/day of PM for 14 days. Body weights were measured weekly, and vaginal epithelium cells were monitored daily. The uterus was dissected at the end of the treatment period, weighed and examined for histomorphometry.

Results

There were a decrease in body weight and an increase in uterine weight, uterine, endometrium and myometrium areas, uterine gland numbers, and percent of cornified cell which were dependent on doses of E and PM treatments.

Conclusions

Of the three assays proposed, although all are reliable and had critical read-out, measurements of body and uterine weights is likely convenient and simple, but the uterotropic assay needs to kill the animals. Vaginal cytology assay appears most promising for sensitivity and shortening the duration of the assay. Compared to those of E, the estrogenic activity of PM at concentrations of 100 and 1,000 mg/kg BW was in the range of 14 to >20 mg/kg BW.
Literature
1.
go back to reference Propper C. The study of endocrine-disrupting compounds: past approaches and new directions. Integr Comp Biol. 2005;45:194–200.PubMedCrossRef Propper C. The study of endocrine-disrupting compounds: past approaches and new directions. Integr Comp Biol. 2005;45:194–200.PubMedCrossRef
2.
go back to reference Gore AC. Endocrine-disrupting chemicals: from basic research to clinical practice. New Jersey: Humana Press; 2007.CrossRef Gore AC. Endocrine-disrupting chemicals: from basic research to clinical practice. New Jersey: Humana Press; 2007.CrossRef
3.
go back to reference Soule HD, Vazquez A, Long A, Albert S, Brennan MA. Human cell line from a pleural effusion derived from a breast cancer. J Nat Cancer Inst. 1973;51:1409–13.PubMed Soule HD, Vazquez A, Long A, Albert S, Brennan MA. Human cell line from a pleural effusion derived from a breast cancer. J Nat Cancer Inst. 1973;51:1409–13.PubMed
4.
go back to reference Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica by MCF-7 proliferation assay. J Reprod Dev. 2008;54:63–7.PubMedCrossRef Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica by MCF-7 proliferation assay. J Reprod Dev. 2008;54:63–7.PubMedCrossRef
5.
go back to reference Chershewasart W, Cheewasopit W, Picha P. The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. J Ethnopharmacol. 2004;93:255–60.CrossRef Chershewasart W, Cheewasopit W, Picha P. The differential anti-proliferation effect of white (Pueraria mirifica), red (Butea superba), and black (Mucuna collettii) Kwao Krua plants on the growth of MCF-7 cells. J Ethnopharmacol. 2004;93:255–60.CrossRef
6.
go back to reference Lee YS, Park JS, Cho SD, Son JK, Cherdshewasart W, Kang KS. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica. J Vet Sci. 2002;3:273–7.PubMed Lee YS, Park JS, Cho SD, Son JK, Cherdshewasart W, Kang KS. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica. J Vet Sci. 2002;3:273–7.PubMed
7.
go back to reference Okamura S, Sawada Y, Satoh T, Sakamoto H, Saito Y, Sumino H, et al. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J Exp Med. 2008;216:341–51.PubMedCrossRef Okamura S, Sawada Y, Satoh T, Sakamoto H, Saito Y, Sumino H, et al. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J Exp Med. 2008;216:341–51.PubMedCrossRef
8.
go back to reference Boonchird C, Mahapanichkul T, Cherdshewasart W. Differential binding with ERα and ERβ of the phytoestrogen-rich plant Pueraria mirifica. Braz J Med Biol Res. 2010;43:195–200.PubMedCrossRef Boonchird C, Mahapanichkul T, Cherdshewasart W. Differential binding with ERα and ERβ of the phytoestrogen-rich plant Pueraria mirifica. Braz J Med Biol Res. 2010;43:195–200.PubMedCrossRef
9.
go back to reference Gray LE, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, et al. Use of the laboratory rat as a model in endocrine disruptor screening and testing. ILAR J. 2004;45:425–37.PubMedCrossRef Gray LE, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, et al. Use of the laboratory rat as a model in endocrine disruptor screening and testing. ILAR J. 2004;45:425–37.PubMedCrossRef
10.
go back to reference Malaivijitnond S, Kiatthaipipat P, Cherdshewasart W, Watanabe G, Taya K. Different effects of Pueraria mirifica, an herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J Pharmacol Sci. 2004;96:428–35.PubMedCrossRef Malaivijitnond S, Kiatthaipipat P, Cherdshewasart W, Watanabe G, Taya K. Different effects of Pueraria mirifica, an herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J Pharmacol Sci. 2004;96:428–35.PubMedCrossRef
11.
go back to reference Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol. 2006;107:354–60.PubMedCrossRef Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol. 2006;107:354–60.PubMedCrossRef
12.
go back to reference Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the estrogenic activity of the wild Pueraria mirifica by vaginal cornification assays. J Reprod Dev. 2007;53:385–93.PubMedCrossRef Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the estrogenic activity of the wild Pueraria mirifica by vaginal cornification assays. J Reprod Dev. 2007;53:385–93.PubMedCrossRef
13.
go back to reference Cherdshewasart W, Sriwatcharakul S, Malaivijitnond S. Variance of estrogenic activity of the phytoestrogen-rich plant. Maturitas. 2008;61:350–7.PubMedCrossRef Cherdshewasart W, Sriwatcharakul S, Malaivijitnond S. Variance of estrogenic activity of the phytoestrogen-rich plant. Maturitas. 2008;61:350–7.PubMedCrossRef
14.
go back to reference Urasopon N, Hamada Y, Asaoka K, Poungmali U, Malaivijitnond S. Isoflavone content of rodent diets and its estrogenic effect on vaginal cornification in Pueraria mirifica-treated rats. Sci Asia. 2008;34:371–6.CrossRef Urasopon N, Hamada Y, Asaoka K, Poungmali U, Malaivijitnond S. Isoflavone content of rodent diets and its estrogenic effect on vaginal cornification in Pueraria mirifica-treated rats. Sci Asia. 2008;34:371–6.CrossRef
15.
go back to reference Sookvanichsilp N, Soonthornchareonnon N, Boonleang C. Estrogenic activity of the dichloromethane extract from Pueraria mirifica. Fitoterapia. 2008;79:509–14.PubMedCrossRef Sookvanichsilp N, Soonthornchareonnon N, Boonleang C. Estrogenic activity of the dichloromethane extract from Pueraria mirifica. Fitoterapia. 2008;79:509–14.PubMedCrossRef
16.
go back to reference Siangcham T, Saenphet S, Saenphet K. Estrogen bioassay of Pueraria mirifica Airy Shaw & Suvatabandhu. J Med Plant Res. 2010;4:741–4. Siangcham T, Saenphet S, Saenphet K. Estrogen bioassay of Pueraria mirifica Airy Shaw & Suvatabandhu. J Med Plant Res. 2010;4:741–4.
17.
go back to reference Malaivijitnond S, Tungmunnithum D, Gittarasanee S, Kawin K, Limjunyawong N. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia. 2010;81:569–76.PubMedCrossRef Malaivijitnond S, Tungmunnithum D, Gittarasanee S, Kawin K, Limjunyawong N. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia. 2010;81:569–76.PubMedCrossRef
18.
go back to reference Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, et al. Estrogen receptor-(beta)-selective ligands alleviated high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem. 2010;285:31292–303.PubMedCrossRef Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, et al. Estrogen receptor-(beta)-selective ligands alleviated high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem. 2010;285:31292–303.PubMedCrossRef
19.
go back to reference Tsai YC, Lee YM, Lam KK, Wu YC, Yen MH, Cheng PY. The role of hypothalamic AMP-activated protein kinase in ovariectomy-induced obesity in rats. Menopause. 2010;17:1194–200.PubMedCrossRef Tsai YC, Lee YM, Lam KK, Wu YC, Yen MH, Cheng PY. The role of hypothalamic AMP-activated protein kinase in ovariectomy-induced obesity in rats. Menopause. 2010;17:1194–200.PubMedCrossRef
20.
go back to reference Zhang YB, Zhang Y, Li LN, Zhao XY, Na XL. Soy isoflavone and its effect to regulate hypothalamus and peripheral orexigenic gene expression in ovariectomized rats fed on a high-fat diet. Biomed Environ Sci. 2010;23:68–75.PubMedCrossRef Zhang YB, Zhang Y, Li LN, Zhao XY, Na XL. Soy isoflavone and its effect to regulate hypothalamus and peripheral orexigenic gene expression in ovariectomized rats fed on a high-fat diet. Biomed Environ Sci. 2010;23:68–75.PubMedCrossRef
21.
go back to reference Chansakaow S, Ishikawa T, Sekine K, Okada M, Higuchi Y, Kudo M, et al. Isoflavonoids from Pueraria mirifica and their estrogenic activity. Planta Med. 2000;66:572–5.PubMedCrossRef Chansakaow S, Ishikawa T, Sekine K, Okada M, Higuchi Y, Kudo M, et al. Isoflavonoids from Pueraria mirifica and their estrogenic activity. Planta Med. 2000;66:572–5.PubMedCrossRef
22.
go back to reference Chansakaow S, Ishikawa T, Seki H, Sekine K, Okada M, Chaichantipyuth C. Identification of deoxymiroestrol as the actual rejuvenating principle of “Kwao Keur”, Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod. 2000;63:173–5.PubMedCrossRef Chansakaow S, Ishikawa T, Seki H, Sekine K, Okada M, Chaichantipyuth C. Identification of deoxymiroestrol as the actual rejuvenating principle of “Kwao Keur”, Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod. 2000;63:173–5.PubMedCrossRef
23.
go back to reference Malaivijitnond S. Medical applications of phytoestrogens from Pueraria mirifica Thai herb. Front Med. 2012;6:8–21.PubMedCrossRef Malaivijitnond S. Medical applications of phytoestrogens from Pueraria mirifica Thai herb. Front Med. 2012;6:8–21.PubMedCrossRef
24.
go back to reference Trisomboon H, Malaivijitnond S, Watanabe G, Taya K. Ovulation block by Pueraria mirifica: a study of its endocrinological effect in female monkeys. Endocrine. 2005;26:33–9.PubMedCrossRef Trisomboon H, Malaivijitnond S, Watanabe G, Taya K. Ovulation block by Pueraria mirifica: a study of its endocrinological effect in female monkeys. Endocrine. 2005;26:33–9.PubMedCrossRef
25.
go back to reference Trisomboon H, Malaivijitnond S, Watanabe G, Cherdshewasart W, Taya K. The Estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys. Endocrine. 2006;29:129–34.PubMedCrossRef Trisomboon H, Malaivijitnond S, Watanabe G, Cherdshewasart W, Taya K. The Estrogenic effect of Pueraria mirifica on gonadotrophin levels in aged monkeys. Endocrine. 2006;29:129–34.PubMedCrossRef
26.
go back to reference Humason GL. Animal tissue techniques. USA: WH Freeman and Company; 1972. Humason GL. Animal tissue techniques. USA: WH Freeman and Company; 1972.
27.
go back to reference Pederson SB, Fuglsig S, Sjogren P. Identification of steroid receptors in human adipose tissue. Eur J Clin Invest. 1996;26:1051–6.CrossRef Pederson SB, Fuglsig S, Sjogren P. Identification of steroid receptors in human adipose tissue. Eur J Clin Invest. 1996;26:1051–6.CrossRef
28.
go back to reference Anwar A, McTernan PG, Anderson LA, Askaa J, Moody CG, Barnett AH, et al. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes Metab. 2001;3:338–49.PubMedCrossRef Anwar A, McTernan PG, Anderson LA, Askaa J, Moody CG, Barnett AH, et al. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes Metab. 2001;3:338–49.PubMedCrossRef
29.
go back to reference Breton AB, Cockrum RR, Austin KJ, Cammack KM, Ford SP, Hess BW, et al. Hypothalamic expression of genes for appetite regulators and estrogen α estrogen β and leptin receptors in obese dams and their fetuses. Animal. 2011;5:1944–8.PubMedCrossRef Breton AB, Cockrum RR, Austin KJ, Cammack KM, Ford SP, Hess BW, et al. Hypothalamic expression of genes for appetite regulators and estrogen α estrogen β and leptin receptors in obese dams and their fetuses. Animal. 2011;5:1944–8.PubMedCrossRef
30.
go back to reference Joyner JM, Hutley LJ, Cameron DP. Estrogen receptors in human preadipocytes. Endocrine. 2001;15:225–30.PubMedCrossRef Joyner JM, Hutley LJ, Cameron DP. Estrogen receptors in human preadipocytes. Endocrine. 2001;15:225–30.PubMedCrossRef
31.
go back to reference Nazz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology. 2003;144:3315–20.CrossRef Nazz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology. 2003;144:3315–20.CrossRef
32.
go back to reference Silva LE, Castro M, Amaral FC, Antunes-Rodrigues J, Elias LL. Estradiol-induced hypophagia is associated with the differential mRNA expression of hypothalamic neuropeptides. Braz J Med Biol Res. 2010;43:759–66.PubMedCrossRef Silva LE, Castro M, Amaral FC, Antunes-Rodrigues J, Elias LL. Estradiol-induced hypophagia is associated with the differential mRNA expression of hypothalamic neuropeptides. Braz J Med Biol Res. 2010;43:759–66.PubMedCrossRef
33.
go back to reference Saruhan BG, Ozdemir N. Effect of ovariectomy and of estrogen treatment on the adrenal gland and body weight in rats. Saudi Med J. 2005;26:1705–9.PubMed Saruhan BG, Ozdemir N. Effect of ovariectomy and of estrogen treatment on the adrenal gland and body weight in rats. Saudi Med J. 2005;26:1705–9.PubMed
34.
go back to reference Mehasseb MK, Panchal R, Taylor AH, Brown L, Bell SC, Habiba M. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011;95:2228–35.PubMedCrossRef Mehasseb MK, Panchal R, Taylor AH, Brown L, Bell SC, Habiba M. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011;95:2228–35.PubMedCrossRef
35.
go back to reference Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology. 1997;138:863–70.PubMed Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology. 1997;138:863–70.PubMed
36.
go back to reference Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 1998;139:4252–63.PubMed Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 1998;139:4252–63.PubMed
37.
go back to reference Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A using both the ovariectomized rat model used in 1933 and additional assays. Toxicol Lett. 2000;115:231–8.PubMedCrossRef Ashby J, Odum J, Paton D, Lefevre PA, Beresford N, Sumpter JP. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A using both the ovariectomized rat model used in 1933 and additional assays. Toxicol Lett. 2000;115:231–8.PubMedCrossRef
38.
go back to reference Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H. Ability of xeno- and phytoestrogens to modulate expression of uterotropic activity. J Steroid Biochem Mol Biol. 2000;73:1–10.PubMedCrossRef Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H. Ability of xeno- and phytoestrogens to modulate expression of uterotropic activity. J Steroid Biochem Mol Biol. 2000;73:1–10.PubMedCrossRef
39.
go back to reference Stroheker T, Chagnon MC, Pinnert MF, Berges R, Canivenc-Lavier MC. Estrogenic effects of food wrap packaging xenoestrogens and flavonoids in female Wistar rats: a comparative study. Reprod Toxicol. 2003;17:421–32.PubMedCrossRef Stroheker T, Chagnon MC, Pinnert MF, Berges R, Canivenc-Lavier MC. Estrogenic effects of food wrap packaging xenoestrogens and flavonoids in female Wistar rats: a comparative study. Reprod Toxicol. 2003;17:421–32.PubMedCrossRef
40.
go back to reference Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: immunohistochemical studies. J Sex Med. 2006;3:804–14.PubMedCrossRef Pessina MA, Hoyt RF Jr, Goldstein I, Traish AM. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: immunohistochemical studies. J Sex Med. 2006;3:804–14.PubMedCrossRef
41.
go back to reference Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007;4:609–19.PubMedCrossRef Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007;4:609–19.PubMedCrossRef
42.
go back to reference Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry. 2004;65:995–1016.PubMedCrossRef Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry. 2004;65:995–1016.PubMedCrossRef
43.
go back to reference Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest. 1990;201(Suppl):3–23. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest. 1990;201(Suppl):3–23.
44.
go back to reference Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001;16:1363–9.PubMedCrossRef Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001;16:1363–9.PubMedCrossRef
45.
go back to reference Chiechi LM, Secreto G, D’Amore M, Fanelli M, Venturelli E, Cantatore F, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitus. 2002;42:295–300.CrossRef Chiechi LM, Secreto G, D’Amore M, Fanelli M, Venturelli E, Cantatore F, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitus. 2002;42:295–300.CrossRef
46.
go back to reference File SE, Jarrett N, Fluck E, Duffy R, Casey K, Wiseman H. Eating soya improves human memory. Psychophamacology. 2001;157:430–6.CrossRef File SE, Jarrett N, Fluck E, Duffy R, Casey K, Wiseman H. Eating soya improves human memory. Psychophamacology. 2001;157:430–6.CrossRef
47.
go back to reference Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–71.PubMedCrossRef Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–71.PubMedCrossRef
48.
go back to reference Al-Azzawi F, Wahab M. Effectiveness of phytoestrogens in climacteric medicine. Ann NY Acad Sci. 2010;1205:262–7.PubMedCrossRef Al-Azzawi F, Wahab M. Effectiveness of phytoestrogens in climacteric medicine. Ann NY Acad Sci. 2010;1205:262–7.PubMedCrossRef
49.
go back to reference Cherdshewasart W, Sriwatcharakul S. Major isoflavonoid contents of the 1-year-cultivated phytoestrogen-rich herb, Pueraria mirifica. Biosci Biotechnol Biochem. 2007;71:2527–33.PubMedCrossRef Cherdshewasart W, Sriwatcharakul S. Major isoflavonoid contents of the 1-year-cultivated phytoestrogen-rich herb, Pueraria mirifica. Biosci Biotechnol Biochem. 2007;71:2527–33.PubMedCrossRef
Metadata
Title
Simple, sensitive and reliable in vivo assays to evaluate the estrogenic activity of endocrine disruptors
Authors
Kanya Anukulthanakorn
Sukanya Jareonporn
Suchinda Malaivijitnond
Publication date
01-01-2014
Publisher
Springer Japan
Published in
Reproductive Medicine and Biology / Issue 1/2014
Print ISSN: 1445-5781
Electronic ISSN: 1447-0578
DOI
https://doi.org/10.1007/s12522-013-0161-1

Other articles of this Issue 1/2014

Reproductive Medicine and Biology 1/2014 Go to the issue